Related Experiment Video
Updated: Aug 17, 2026

Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
Combination thrombolytic therapy: a comparison of simultaneous and sequential regimens of tissue plasminogen
J A Morris1, D W Muller, E J Topol
1Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor.
Insights
Rescue angioplasty after tissue plasminogen activator (t-PA) therapy for heart attacks showed no difference in vessel patency. However, combining urokinase with t-PA before or during angioplasty reduced reocclusion rates.
Area of Science:
- Cardiology
- Interventional Cardiology
- Thrombolytic Therapy
Background:
- Coronary angioplasty after failed tissue plasminogen activator (t-PA) therapy for acute myocardial infarction is linked to high reocclusion rates and mortality.
- Pre-angiography combination therapy with t-PA and urokinase shows promise in reducing post-angioplasty reocclusion.
Purpose of the Study:
- To compare the long-term patency of infarct-related arteries following three different thrombolytic strategies during rescue angioplasty for acute myocardial infarction.
- To evaluate the effectiveness of intraprocedural urokinase in improving outcomes compared to t-PA monotherapy or pre-angiographic combination therapy.
Main Methods:
- Retrospective comparison of three groups of patients undergoing rescue coronary angioplasty.
- Group 1: t-PA monotherapy (n=86).
- Group 2: Sequential t-PA/urokinase therapy (n=24).
- Group 3: Simultaneous t-PA/urokinase therapy (n=34).
Main Results:
- No significant difference in immediate post-angioplasty patency rates of the infarct-related artery was observed among the three groups.
- The sequential t-PA/urokinase group had a lower reocclusion rate (13%) than the t-PA alone group (29%) but a higher rate than the simultaneous therapy group (2%).
- The difference in reocclusion rates between the groups was statistically significant (p = 0.003).
Conclusions:
- Intraprocedural urokinase during rescue angioplasty does not improve immediate vessel patency compared to t-PA monotherapy.
- Sequential t-PA/urokinase therapy offers an intermediate reocclusion rate between t-PA monotherapy and simultaneous t-PA/urokinase therapy.
- Simultaneous t-PA/urokinase therapy appears most effective in preventing reocclusion after rescue angioplasty for acute myocardial infarction.
Abstract:
Coronary angioplasty following unsuccessful tissue plasminogen activator (t-PA) therapy for acute myocardial infarction has been associated with a high incidence of subsequent reocclusion of the infarct-related artery, and a relatively high in-hospital mortality. In contrast, the combination of t-PA and urokinase, when given intravenously prior to coronary angiography, appears to be associated with a low incidence of post-rescue angioplasty reocclusion. In order to determine whether intraprocedural urokinase, given at the time of rescue coronary angioplasty for failed t-PA therapy, improves long-term patency of the infarct vessel to the same extent as preangiographic, combination t-PA/urokinase therapy, three thrombolytic treatment strategies were retrospectively compared. The first group included 86 patients undergoing rescue angioplasty after t-PA monotherapy (t-PA alone). The clinical and angiographic outcomes of these patients were compared with those of 24 patients who received intravenous or intracoronary urokinase during rescue angioplasty following unsuccessful t-PA therapy (sequential t-PA/urokinase therapy), and with those of 34 patients undergoing rescue coronary angioplasty following unsuccessful therapy with the combination of intravenous t-PA and urokinase (simultaneous therapy). There was no difference in postangioplasty patency rate of the infarct-related artery between the three groups. However, the sequential t-PA/urokinase regimen was associated with a subsequent reocclusion rate that was lower than the rate that occurred in the t-PA monotherapy group but higher than the rate in the simultaneous t-PA/urokinase group (13 versus 29 versus 2%, respectively; p = 0.003).(ABSTRACT TRUNCATED AT 250 WORDS)
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Clot Retraction and Fibrinolysis
Acute Coronary Syndrome I: Introduction
Peripheral Artery Disease III: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

